Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Assessing fluid responsiveness in patients with impaired consciousness

Official title: Comparing Fluid Responsiveness Assessment Methods in Patients With Impaired Consciousness: A Comprehensive Crossover Study Examination

Run by Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology · NCT06180902 · Data updated 2026-11-12

This study tests different ways to see how well patients with low blood pressure and impaired consciousness respond to fluid treatment in order to improve their care in the ICU.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment222 (estimated)
SponsorFederal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology
Academic / other
Locations1 site (Moscow)
StatusRecruiting
StartedJanuary 16, 2024
Main results expectedMay 20, 2026
Study endsMay 20, 2026
Registry record updatedJanuary 23, 2026
Trial IDNCT06180902 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are hospitalized in an intensive care unit with arterial hypotension and impaired consciousness.

Probably not a fit

Patients with pulmonary edema, severe chronic kidney disease, or increased intracranial pressure may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of various methods for assessing fluid responsiveness in patients experiencing hypotension and cognitive impairment. It employs tests such as evaluating the inferior vena cava's diameter, passive leg raising (PLR), and fluid challenge (FC) to determine how well patients respond to infusion therapy. The study aims to address the limitations of traditional static measurements like central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP), particularly in patients with altered consciousness levels. By focusing on more accessible and cost-effective methods, the research seeks to improve management strategies for hypotension in intensive care settings.

Why it matters

Potential benefit: If successful, this study could enhance the management of hypotension in critically ill patients, leading to better clinical outcomes.

How similar studies have gone: While traditional methods have been questioned, the use of PLR and FC tests has shown promise in other studies, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years.
* Hospitalization in an intensive care unit
* Level of consciousness on the FOUR scale ≤ 12 points
* Planned infusion therapy
* Presence of a central venous catheter or direct indication for catheterization
* The decision of the medical council to include the patient in the study

Exclusion Criteria:

* Pulmonary edema
* Absence of one or both lower extremities
* Chronic kidney disease according to KDIGO classification ≥ stage 3b
* Acute kidney injury grade 3
* Documented or suspected increased intracranial pressure (cerebral edema, brain compression, hydrocephalus, etc.).
* Presence of mitral valve regurgitation \> grade 1
* Presence of aortic valve regurgitation \> grade 1
* Patients previously enrolled in the "COMPASS" study in the period of 12 preceding hours

Where it's running

  • Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
    Moscow, Russia
    Recruiting

Study contacts

  • Principal investigator: Valery Likhvantsev, PhD — Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology
  • Study coordinator: Valery Likhvantsev, PhD
  • Email: lik0704@gmail.com
  • Phone: +79036235982

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.